# Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

> **NCT01399827** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 2 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)
- Deficient Emotional Self-Regulation (DESR)

## Interventions

- **DRUG:** ADHD Medication
- **DRUG:** Omega-3 Fatty Acids

## Key facts

- **NCT ID:** NCT01399827
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01399827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01399827, "Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01399827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*